Clinical Trial

Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients

Study acronym: CONFIRM
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 18, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
There are currently no good ways of measuring levels of scarring in the hearts of patients with advanced kidney disease and patients on dialysis, although recent research has shown a new cardiac MRI technique, called native T1 mapping, may provide a solution to this. To assess the accuracy of this novel technique in dialysis patients, it is essential to undertake a study which compares native T1 mapping to actual levels of scarring in the hearts of patients on dialysis.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2018-07-02; most recent amendment 2025-04-15.
Status change: Not Yet Recruiting → Recruiting 2019-03-29
Trial Details
NCT Number NCT03586518
Lead Sponsor University of Leicester
Collaborators: University Hospitals, Leicester, St George's, University of London
Conditions End Stage Kidney Disease, Fibrosis Myocardial
Enrollment 9 participants
Start Date 2019-11-03
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-18